SL STRATEGIES, LLC

Lobbying for BAVARIAN NORDIC · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income · posted May 4, 2026

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund

Health Issues

Pandemic All Hazards Preparedness Act (PAHPA) reauthorization

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.